Currently, DKK1 has been recognized as a biomarker of atherosclerosis due to its significantly increased expression in atherosclerotic lesions, which contributes to endothelial activation, inflammatory responses, coronary atherosclerosis, and acute IS [13–15]. Here, DKK1 is linked to coronary atherosclerosis.